Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
What Did the Research Find
When indicated, the original medium was added with phosphonacetic acid (PAA
2009 Nov;18(11):29748
Retatrutide (LY3437943) is Eli Lillys experimental triple-agonist drug that activates: GLP-1 (Glucagon-like peptide-1) reduces appetite and slows digestion GIP (Glucose-dependent insulinotropic peptide) enhances insulin sensitivity Glucagon receptor increases fat metabolism and energy expenditure In phase-2 trials, Retatrutide achieved up to 24% body-weight reduction rivaling or even surpassing bariatric surgery outcomes
BMC Complement Alternative Medicine 19 , 97
PMID 14628964
US$ 27.77
US$ 21.98
US$ 29.79
US$ 24.83
US$ 20.53
US$ 20.07
US$ 26.21
US$ 26.75
US$ 23.73
